PetVivo Holdings, Inc. (PETV)

$2.45

-0.07 (-2.78%)
Rating:
Recommendation:
-
Symbol PETV
Price $2.45
Beta 1.971
Volume Avg. 0.04M
Market Cap 24.592M
Shares () -
52 Week Range 1.2-5.14
1y Target Est -
DCF Unlevered PETV DCF ->
DCF Levered PETV LDCF ->
ROE -253.14% Strong Sell
ROA -113.39% Strong Sell
Operating Margin -
Debt / Equity 34.59% Neutral
P/E -
P/B 5.75 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest PETV news


Healthcare
Medical Devices
NASDAQ Capital Market

PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.